IPP Bureau
Xspray Pharma licenses patent rights to Handa Therapeutics, secures royalty agreement
By IPP Bureau - August 17, 2025
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
AN2 Therapeutics begins first-in-human trial of oral AN2-502998 for chagas disease
By IPP Bureau - August 17, 2025
Phase 1 dosing is expected to finish by the end of 2025
STEER World achieves 200 kg/hr continuous granulation with patented INTEGRAAL system
By IPP Bureau - August 17, 2025
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
Alkem reports posts Q1 FY26 net profit 22% higher at 664.3 Cr
By IPP Bureau - August 17, 2025
Alkem’s domestic business grew 9.7 per cent versus the Indian pharmaceutical market growth of 8.5 per cent
QMS Medical Allied Services reports 31.65% rise in Q1 FY26 PAT to Rs. 3.15 Cr
By IPP Bureau - August 17, 2025
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
Firstsource and Guidehealth partner to advance AI-enabled value-based care for health plans
By IPP Bureau - August 17, 2025
The collaboration will combine Firstsource’s AI-first approach with Guidehealth’s expertise in value-based care innovation
UFlex posts Q1 FY26 PAT at Rs. 58 Cr
By IPP Bureau - August 17, 2025
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
Anthem Biosciences posts Q1 FY26 PAT at Rs. 135.8 Cr
By IPP Bureau - August 17, 2025
The CRDMO segment contributed Rs. 452.7 crore, recording a robust 70.5 per cent YoY increase
Zydus’ SEZ II, Ahmedabad plant clears USFDA inspection with nil observations
By IPP Bureau - August 16, 2025
The inspection concluded with NIL observations
Cohance Lifesciences reports 13% revenue growth in Q1 FY26
By IPP Bureau - August 16, 2025
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
AbbVie to invest $195 million to expand API manufacturing in North Chicago
By IPP Bureau - August 16, 2025
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
Brightmark and Lewis Salvage recycle over 1 million pounds of medical plastics
By IPP Bureau - August 16, 2025
Medical plastics make up about 25 per cent of the 14,000 tons of waste generated daily in US healthcare facilities
AAVantgarde Bio receives FDA fast track designation for AAVB-039 in stargardt disease
By IPP Bureau - August 16, 2025
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs
By IPP Bureau - August 16, 2025
Attorney General Ken Paxton sued pharmaceutical giant Eli Lilly for bribing and illegally inducing medical providers to prescribe its most profitable drugs
